March 30, 2026
Will it get better?
As we close out the first quarter of 2026 the insulin pump companies are likely saying goodbye and good riddance. Traditionally the first quarter is the slowest for pump sales but in this case the first quarter has been brutal for share prices. Not one of the major pump companies Insulet, Tandem, Beta Bionics or MiniMed stands in positive territory on a year-to-date basis. Insulet recently hit a. 52 week low. The question now is will it get worse before it gets better or is now the time to jump in?
Before we answer that lets make something . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
